Adel Helmy
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| IL-1ra Dose-range Study for Moderate-to-severe TBI Patients (NCT02997371) | Adel Helmy | 2017-10-01 |
Track Adel Helmy automatically
Every clearance here is in the API, with alerts when new ones post.